Mr. Molloy has twenty-five years of experience in public, private and VC funded healthcare companies. He serves on the Board and the Audit Committee at publicly listed CAS Medical (NASDAQ – CASM) and Silicon Valley start-up Velano Vascular. He was previously a Board member at MiCardia, LMA (acquired by Teleflex in 2012 after its public offering) and VasoNova. Paul was a practicing CRNA until joining Datascope Corp in NJ in 1989, obtaining his MBA from the University of Chicago’s Booth School of Business and managing through successive executive positions with leading medical device firms. He has extensive global industry connections and has traveled, lived and worked in Europe and Asia and has substantial experience in establishing and managing operations in these regions.